BioSpace

Roivant, the 'inveterate drug hunters', enters commercial era with Lisraya

CEO Matt Gline is juggling Roivant Sciences' first solo drug launch and several maturing programs as the hub-and-spoke company sets its sights on a massive turning point into commercial viability.

作者 BioSpace

1 分钟阅读
Roivant, the 'inveterate drug hunters', enters commercial era with Lisraya
Roivant, the 'inveterate drug hunters', enters commercial era with Lisraya

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Health Tech相关内容

相关洞察